Neurocysticercosis: Combined Treatment With Praziquantel (PZQ) and Albendazole (ABZ)
Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if combination drug therapy of praziquantel and
albendazole is safe and effective to cure neurocysticercosis.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Universidad Peruana Cayetano Heredia
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)